VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 200 filers reported holding VAXCYTE INC in Q4 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $43,078,100 | +2.1% | 845,000 | 0.0% | 3.18% | -2.4% |
Q2 2023 | $42,199,300 | +51.1% | 845,000 | +13.4% | 3.26% | +77.0% |
Q1 2023 | $27,922,600 | -19.7% | 745,000 | +2.8% | 1.84% | -15.1% |
Q4 2022 | $34,763,750 | +75.8% | 725,000 | -12.0% | 2.17% | +130.1% |
Q3 2022 | $19,769,000 | +10.3% | 823,705 | 0.0% | 0.94% | +6.8% |
Q2 2022 | $17,924,000 | +117.7% | 823,705 | +97.6% | 0.88% | +159.7% |
Q1 2021 | $8,235,000 | -25.7% | 416,937 | 0.0% | 0.34% | -28.4% |
Q4 2020 | $11,078,000 | -65.6% | 416,937 | -36.0% | 0.48% | -70.2% |
Q3 2020 | $32,159,000 | +15.4% | 651,255 | -26.2% | 1.60% | -11.3% |
Q2 2020 | $27,877,000 | – | 881,898 | – | 1.80% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 4,168,718 | $100,049,000 | 34.21% |
Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $45,299,000 | 18.86% |
Pivotal bioVenture Partners Investment Advisor LLC | 776,039 | $18,625,000 | 6.81% |
Kynam Capital Management, LP | 698,638 | $16,767,000 | 3.53% |
GREAT POINT PARTNERS LLC | 600,000 | $14,400,000 | 3.47% |
Frazier Life Sciences Management, L.P. | 1,547,405 | $37,138,000 | 2.86% |
Ghost Tree Capital, LLC | 360,000 | $8,640,000 | 2.42% |
RA Capital Management | 4,581,203 | $109,949,000 | 2.35% |
Opaleye Management Inc. | 190,000 | $4,560,000 | 1.88% |
TPG GP A, LLC | 3,285,504 | $78,852,000 | 1.29% |